Brain and skeletal muscle monoamine oxidase activity in schizophrenia

Related Experiment Videos

Insights

Studies on chronic schizophrenics show no definitive evidence of reduced brain monoamine oxidase (MAO) activity, suggesting it

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Monoamine oxidase (MAO) activity in postmortem brain specimens of chronic schizophrenics has been investigated.
  • Previous studies on MAO activity in schizophrenia brains yielded inconclusive results due to potential errors in postmortem analysis.

Purpose of the Study:

  • To evaluate the role of monoamine oxidase (MAO) activity in the pathogenesis of psychosis.
  • To investigate the correlation between brain and platelet MAO activities.
  • To explore the potential inhibitory effects of neuroleptic drugs on human brain MAO activity.

Main Methods:

  • Analysis of postmortem brain specimens from chronic schizophrenics and comparison groups.
  • Comparison of MAO activity in brain and platelet samples.
  • Review of indirect evidence from spinal fluid and postmortem studies regarding neuroleptic drug effects.

Main Results:

  • No consistent evidence for decreased MAO activity in the brains of schizophrenic patients was found.
  • Significant correlation between brain and platelet MAO activities in humans was absent.
  • Decreased MAO activity was observed in the skeletal muscle of psychotic patients compared to controls.

Conclusions:

  • Reduced brain MAO activity is unlikely to be significant in the pathogenesis of psychosis, as substantial inhibition is required for functional impact.
  • Peripheral MAO activity in skeletal muscle may serve as a nonspecific marker for psychopathology vulnerability.
  • Further research is needed to clarify the role of MAO in psychiatric disorders.

Related Concept Videos